Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials

Richard B. Lipton, Larry Charleston, Cristina Tassorelli, Thomas Brevig, Joe Hirman, Roger Cady

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials'. Together they form a unique fingerprint.

Medicine & Life Sciences